Profiel
Caroline Fichtner is currently the Director at Thermosome GmbH and the Principal & Authorized Signatory at High-Tech Gründerfonds Management GmbH.
Previously, she worked as an Analyst at PolyTechnos Venture-Partners GmbH.
Dr. Fichtner holds a graduate degree from Ruhr-Universität Bochum, an undergraduate degree from the University of Münster, and a doctorate degree from Heinrich-Heine-Universität Düsseldorf.
Actieve functies van Caroline Fichtner
| Bedrijven | Functie | Begin |
|---|---|---|
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance HTGF invests in companies located in Germany. The firm focuses on chemistry, digital tech, industrial tech and life sciences sectors. It participates in pre-seed and seed stage capital requirements with an investment size of EUR 0.8 - 30 million. It makes co-investments, follow-on financing and also acts as a lead investor. | Private Equity Investor | 01-03-2006 |
Thermosome GmbH
Thermosome GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs for solid tumors | Directeur/Bestuurslid | - |
Eerdere bekende functies van Caroline Fichtner
| Bedrijven | Functie | Einde |
|---|---|---|
PolyTechnos Venture-Partners GmbH
PolyTechnos Venture-Partners GmbH Investment ManagersFinance PTVP originally focused on early-stage investing in advanced technology sectors, then evolved towards later-stage investments. Their portfolio companies are typically European high-growth companies where they identified a special situation likely to create significant value within a short period of time, a unique business model, limited technology risk, limited burn rate, and an identified value inflection point for a global trade sale or an IPO. PTVP's focus is on German-speaking countries. They provide hands-on support to promote the global development of their investee companies. Their portfolio is invested in sectors including software, information technology, life sciences, energy and clean technology, as well as in companies born of the convergence of these fields. | Private Equity Analist | 31-05-2002 |
Opleiding van Caroline Fichtner
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Ruhr-Universität Bochum
Ruhr-Universität Bochum Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Münster
University of Münster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heinrich-Heine-Universität Düsseldorf
Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance HTGF invests in companies located in Germany. The firm focuses on chemistry, digital tech, industrial tech and life sciences sectors. It participates in pre-seed and seed stage capital requirements with an investment size of EUR 0.8 - 30 million. It makes co-investments, follow-on financing and also acts as a lead investor. | Finance |
PolyTechnos Venture-Partners GmbH
PolyTechnos Venture-Partners GmbH Investment ManagersFinance PTVP originally focused on early-stage investing in advanced technology sectors, then evolved towards later-stage investments. Their portfolio companies are typically European high-growth companies where they identified a special situation likely to create significant value within a short period of time, a unique business model, limited technology risk, limited burn rate, and an identified value inflection point for a global trade sale or an IPO. PTVP's focus is on German-speaking countries. They provide hands-on support to promote the global development of their investee companies. Their portfolio is invested in sectors including software, information technology, life sciences, energy and clean technology, as well as in companies born of the convergence of these fields. | Finance |
Thermosome GmbH
Thermosome GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs for solid tumors | Health Technology |
















